Kiora Pharmaceuticals Inc.

KPRX | NASDAQ

Price Alert Chart Builder DCF Calculator

$2.68

-$0.08 (-2.90%)

At close: Sep 21, 2026, 4:00 PM ET

$2.69

+$0.01 (+0.37%)

After-hours: Sep 21, 2026, 5:10 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

-2.90%

(1D)

Rating

Updated: Sep 12, 2026

23.5

Fundamentals Weak

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $11.88M

1D Range

2.65 2.73

52W Range

1.77 2.95

Valuation (TTM)

PE -1.07

PB 0.70

EV/EBITDA 0.46

Valuation (NTM)

Forward PE N/A

Forward PEG 0.02

Price Target N/A

Cash Flow

FCF Yield -72.5%

SBC Adj. FCF Yield -75.4%

SBC Impact -4.0%

Margins

Gross Margin 0.0%

Operating Margin 0.0%

FCF Margin N/A

Growth (CAGR)

Revenue 3Y | 5Y -150.0% | 0.0%

Dil EPS 3Y | 5Y -164.4% | 82.3%

FCF 3Y | 5Y -171.1% | 9.5%

Returns

ROA -46.2%

ROE -63.4%

ROIC -53.2%

Financial Health

Net Cash

$16.51M

Current Ratio 8.97

Interest Coverage 0.00

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Kiora Pharmaceuticals, Inc., a specialty pharmaceutical firm operating at the clinical stage, is dedicated to the creation and commercialization of treatments for various ophthalmic conditions across ...

Sector Healthcare

Industry Biotechnology

Employees 13

IPO Date Feb 12, 2015

Website www.kiorapharma.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.